This evidence brief summarises key issues and priorities for action in Europe and Central Asia on HIV testing. It is largely based on data collected in 2021 by the European Centre for Disease Prevention and Control (ECDC) to monitor implementation of the 2004 Dublin Declaration.
This evidence brief summarises key issues and priorities for action in Europe and Central Asia on PrEP. It is largely based on data collected between March and September 2021 by the European Centre for Disease Prevention and Control (ECDC) to monitor implementation of the 2004 Dublin Declaration.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the the period 3-9 July 2022 and includes updates on COVID-19, monkeypox, West Nile virus, mass gatherings in Hajj - Saudi Arabia, Vibrio growth, MERS-CoV, and Ebola virus disease.
This document provides an overview of key considerations for the provision of the HIV continuum of care in the context of displaced people from Ukraine in the EU/EEA.
In 2018, 3 233 confirmed cases of invasive meningococcal disease (IMD), including 324 deaths, were reported in 30 European Union/European Economic Area (EU/EEA) Member States.
HIV continues to affect the health and wellbeing of people in Europe. In 2020, 14,971 new HIV diagnoses were reported in 29 countries of the EU/EEA. This video explain how we can reduce these numbers
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 29 May-4 June 2022 and includes updates on West Nile virus infection, COVID-19, Influenza, people displaced from Ukraine, hepatitis, Ebola, monkeypox, cholera, chikungunya and dengue.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 1-7 May 2022 and includes updates on COVID-19, Influenza, the arrival of people displaced from Ukraine to the EU following Russia's invasion of Ukraine, hepatitis, Ebola, Middle East respiratory syndrome coronavirus, chikungunya and dengue.